Protalix BioTherapeutics, Inc. (PLX)
NYSE American · Manufacturing · Biological products, (no diagnostic substances)
PLX price, last 12 months
Key stats
- Previous close
- $3.02
- Open
- $2.97
- Day range
- $2.92 – $3.14
- 52-week range
- $1.65 – $3.19
- Volume
- 1.6M
- Avg volume (20 days)
- 1.1M
- Market cap
- $257.2M
Performance
Technicals and fundamentals
About Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NYSE American
- Market cap
- $257.2M